Bioavailability of EPA + DHA in a SMEDS Formulation

Inclusion Criteria: * Body mass index 18.50-29.99 kg/m2 * Good health on basis of medical history and routine laboratory tests * Score of at least 7 on vein access scale * Willing and able to remain at site for extended testing periods, including a total of 4 overnight stays, and to consume foods and products provided by study staff on those days * Willing to abstain from alcohol for 24 h prior to clinic admission * No plans to change smoking habits or other nicotine use * Willing to undergo 13 venipunctures during each treatment period Exclusion Criteria: * Screening lab test of clinical significance * Positive urine drug screen * Clinically significant endocrine, cardiovascular, renal, hepatic, pulmonary, pancreatic, neurologic, gastrointestinal or biliary disorder * Uncontrolled hypertension * Recent history or presence of cancer * Difficulty swallowing capsules * Recent blood donation or blood loss * Recent consumption of high-dose fish oil or fish * Recent use of any prescribed medication or over-the-counter medicinal products, including herbal or dietary supplements (except daily omega-3 fatty acid-free vitamin and/or mineral supplement or occasional use of acetaminophen or non-steroidal anti-inflammatory drugs) * Signs or symptoms of active infection or has recently taken antibiotics * Recent history or strong potential for drug or alcohol abuse * Pregnant, planning to be pregnant during the study, lactating or of childbearing potential and unwilling to commit to use of a medically approved form of contraception throughout the study (note: hormonal contraceptive use is not allowed)